tbuckley/cabot-search huggingface dataset:
Trajectories of Patient-Reported Outcomes after Idecabtagene Vicleucel Vs. Ciltacabtagene Autoleucel CAR T-Cell Therapy Among Patients with Relapsed/Refractory Multiple Myeloma in Standard of Care
Authors: Xiaoyin Li, Carina E. Ferraris, Gabriel De Avila, Lisa M. Gudenkauf, Aasha I. Hoogland, Oanh Nguyen, Yvelise Rodriguez, Sylvia L. Crowder, Nathan Parker, Tiffany L. Carson, Rachid C. Baz, Kenneth H. Shain, Brandon Blue, Ariel Grajales-Cruz, Melissa Alsina, Ciara Louise Freeman, Omar Castaneda, Taiga Nishihori, Hien Liu, Frederick L. Locke, Heather S.L. Jim, Doris K. Hansen, Lauren C. Peres, Laura B. Oswald
Journal: Blood (2024)
Efficacy and Safety of Beceltinib Capsules in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia: A Multicenter, Randomized, Open-Label, Phase 1/2 Study
Authors: Hu Zhou, Xuewen Song, Zengmei Sheng, Feng Zhang, Guocai Wu, Lidong Zhao, ZePing Zhou, Lihong Shou, Lili Chen, Xiaotao Wang, Jian Huang, Rong Fu, Dan Chen, Ruibin Huang, Zongjiu Jiao, Jian Lu, Yajun Ruan, Yu Jiao
Journal: Blood (2024)
Efficacy and Safety of Bendamustine, Pomalidomide, Sintilimab in Patients with Recurrent or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
Authors: Haiyan Yang, Shengsheng Zhou, Fengxiang Huang, Meiwei Li, Wenguang Bao, Man Wang, Dong Lan, Zhigang Peng
Journal: Blood (2024)
Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects
Authors: Lionel Blanc, Jared Huston, Carlos Bravo-Iñiguez, Julien Papoin, Maaryj Ahmad, Isabella Mirro, Caroline Benner, Brooke Le, Melanie McWade, Christopher J Czura, Alejandro Covalin, Navid Khodaparast
Journal: Blood (2024)
Impact of Infectious Complications Should be Considered When Choosing Chemotherapy for Elderly Acute Myeloid Leukemia Fit Patients: Results of a Large Monocentric Retrospective Study
Authors: Erika Borlenghi, Erika Borlenghi, Irene Terrenato, Margherita Oberti, Giulia Soverini, Angelica Spolzino, Elisa Cerqui, Simone Maifredi, Ester Lovato, Lorenzo Masina, Francesca Federico, Diego Bertoli, Francesco Marchesi, Giuseppe Rossi, Alessandra Tucci
Journal: Blood (2024)
CAR-T Therapy Versus Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: Systematic Review and Metanalysis of Toxicity and Response
Authors: Mansi Mehta, Devang Namjoshi, Bolivia Crocete Aloysia Fernandes, Vaibhavi Mukhtiar, Charmi Bhanushali, Madhan Srinivasan Kumar, Gunjan Rana, Jaison Lawrence Alexander Santhi, Tanisha Mishra, Muthalagu Ramanathan
Journal: Blood (2024)
Efficacy and Safety of Revumenib in the Treatment of Acute Myeloid Leukemia with KMT2A Rearrangements or NPM1 Mutations: A Systematic Review
Authors: Abdur Jamil, Zaheer Qureshi, Rimsha Siddique, Gillian Kupakuwana-Suk, Faryal Altaf, Insija Selene
Journal: Blood (2024)
Matrine Synergistically Promotes Non-Toxic-Dose RLS3 Induced Ferroptosis in Acute Myeloid Leukemic Cells with MLL Translocation
Authors: Yaonan Hong, Fanhua Yu, Man Li, Jingjie Dong, Yingying Shen, Xiawan Yang, Keding Shao, Qi Liu, Peicheng Wang, Yuhong Zhou, Yiping Shen, Dijiong Wu
Journal: Blood (2024)
Epidemiological Analysis and Overall Survival of Leukemia in Adults in a Developing Middle Eastern Country over 18 Years
Authors: Ahmed A Abdulelah, Zaid A Abdulelah, Aseel Saadeh, Omar Al Ta'ani, Lina AlQirem, Abdulrahman Alhajahjeh, Hikmat Abdel-Razeq, Michael Haddadin
Journal: Blood (2024)
Aberrant Mitochondrial Iκbα/NF-Κb-Signaling in Lung Cancer Cells Mediates Endothelial Cell Activation and Platelets Aggregation, Facilitating Lung Cancer Metastasis and Cancer-Associated Thrombosis
Authors: Giovanna Carra', Rita Vacca, Roberta Basile, Alessio Menga, Alessandro Morotti
Journal: Blood (2024)
Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring <i>IDH2</i> and <i>RAS</i> Signaling Gene Mutations
Authors: Brian J. Ball, Jianying Zhang, Michelle Afkhami, Marjorie Robbins, Lauren Chang, Samantha Humpal, Vania Porras, Yilun Liu, Tim W Synold, Sarah Farzinkhou, Azra Borogovac, Paul B. Koller, Hoda Pourhassan, Vaibhav Agrawal, Anthony S. Stein, Mary-Elizabeth M. Percival, Alexey V. Danilov, Guido Marcucci
Journal: Blood (2024)
Impact of Autologous Hematopoietic Stem Cell Transplantation on Newly Diagnosed Multiple Myeloma with Different Cytogenetic Profiles: A Brazilian Unicentric Cohort
Authors: Maria Gabriella Cordeiro, Elvira D. R. P. Velloso, Aline de Medeiros Leal, Joaquim Gasparini Santos, Leonardo Otuyama, Evelin Ramos, Fernanda Salles Seguro, Marcelo Junqueira Atanasio, Thales D.M. Pereira, Vanderson Rocha, Gracia Aparecida Martinez
Journal: Blood (2024)
Clinical Factors Associated with Increased Risk of Spinal Cord Compression in Multiple Myeloma Patients: Insights from National Inpatient Sample Database (2016-2020)
Authors: Elvis Obomanu, Colton Frisco Jones, Tarfa Verinumbe, Hilary A Elom, Hasiya Yusuf, Karecia Byfield, Chidiebube Ugwu, Swe Swe Hlaing, Zachary Cohn
Journal: Blood (2024)
Outcomes of Patients with Relapsed Multiple Myeloma Treated with Pomalidomide, Cyclophosphamide, and Dexamethasone Based on Prior Resistance to Anti-CD38 Monoclonal Antibodies
Authors: Marta Hidalgo-Soto, Lucía Martín-Rodríguez, Eugenia Abella Montreal, Inmaculada Fernández-Camacho, Mercedes Gironella Mesa, Yolanda González-Montes, M Teresa Cibeira López, Laura Rosinol Dachs, José Miguel Mateos Pérez, Natalia Tovar, Carlos Fernández de Larrea, Luis Gerardo Rodríguez-Lobato
Journal: Blood (2024)
Fibrin Clot Shields Formation in the Tumor Microenvironment, Induced By Cancer Cells' Hypercoagubility, Serves As Scaffolds for Invasion and Protection Against Anticancer Treatments
Authors: Chi Mai Huong Tran, Patrick Van Dreden, Elisabeth Mbemba, Aurelie Rousseau, Eleftheria Lefkou, Michele Sabbah, Grigoris Gerotziafas
Journal: Blood (2024)
Body Mass Index Trajectory during Triplet Induction Therapy: Clinical Implications in Newly Diagnosed Multiple Myeloma
Authors: Ram Prakash Thirugnanasambandam, Ross S Firestone, Andriy Derkach, Helena Furberg, Tala Shekarkhand, Colin Rueda, Kylee H Maclachlan, Malin Hultcrantz, Sham Mailankody, Dhwani Patel, Oscar Boutros Lahoud, Heather J. Landau, David J. Chung, Gunjan L. Shah, Michael Scordo, Hani Hassoun, Alexander M. Lesokhin, Sergio Giralt, Neha Korde, Saad Z. Usmani, Carlyn Rose Tan, Urvi A. Shah
Journal: Blood (2024)
Early Insights into Real-World Iptacopan Use Among Patients with Paroxysmal Nocturnal Hemoglobinuria in the United States: The Apprise-PNH Data Platform
Authors: David Dingli, Glorian Yen, Nicholas Kuypers, Jincy Paulose, Mohin Chanpura, Soyon Lee, Joseph Barone, Jacob Stutts, Tayler Buchan, Claire Buchan, Inkyu Kim, Jackson Tang, Anem Waheed
Journal: Blood (2024)
Real World Evidence of Daratumumab-Based Treatment in AL Amyloidosis
Authors: Charyguly Annageldiyev, Habib Yazgi, Natasha Venugopal, Jorge Raul Vazquez-Urrutia, Joseph Cioccio, Kentaro Minagawa, Kevin Rakszawski, Natthapol Songdej, Jo Ann Davidson, Shin Mineishi, Seema Naik
Journal: Blood (2024)
Stalled CARS. Examining the Real-World Impact of Waiting for CART in Patients with Multiple Myeloma
Authors: Michael Weise, Muhammad Umair Mushtaq, Shebli Atrash, Al-Ola Abdallah, Joseph P. McGuirk, Forat Lutfi, Barry Skikne, Nausheen Ahmed, Zahra Mahmoudjafari
Journal: Blood (2024)
Correlations between Lesion Avidity, Immune Effector Cell-Associated Neurotoxicity Syndrome Scoring, and Fracture Risk in Patients with Multiple Myeloma Undergoing Chimeric Antigen Receptor T-Cell Therapy
Authors: Bryan Clampitt, Thien Huong Huynh, Chloe Min Chose, Mathew Daniel Nester, Davis Kuruvilla, David Joyce, Odion Binitie, Ciara Louise Freeman, Alexander Lazarides
Journal: Blood (2024)
Cytogenetic Risk Stratification in a Centre Colombian Multiple Myeloma Patients
Authors: Jose Sandoval-Sus, Claudia Sossa, Luis Antonio Salazar, Angela Peña-Castellanos, Manuel Leonidas Rosales Acevedo, Carlos Alberto Orozco Oviedo, Carlos Andres Perez, Katherinee Morales Chacon, Maria Luna-Gonzalez, Ana María Prada-Sepúlveda, Juliana Alvarez, Melanie Tarazona-Bohórquez, Miguel Ochoa
Journal: Blood (2024)
Efficacy of Venetoclax-Based Therapy Followed By Allogeneic Transplantation in Newly Diagnosed and Relapsed/Refractory AML Patients
Authors: Matteo Fanin, Davide Lazzarotto, Alessandra Sperotto, Ilaria Tanasi, Matteo Leoncin, Carmela Gurrieri, Carla Fili, Chiara Callegari, Giulia Battaglia, Erica Simeone, Maria Elena Zannier, Luca Tosoni, Gian Luca Morelli, Melissa Bergnach, Michele Gottardi, Edoardo Tamellini, Sara Consolo, Cristina Skert, Francesco Angotzi, Federica Lessi, Mauro Krampera, Francesca Patriarca, Daniela Damiani, Renato Fanin, Mario Tiribelli
Journal: Blood (2024)
Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) VS Venetoclax Combined with Azacitidine in Elderly Patients with Acute Myeloid Leukemia：a Phase III, Prospective, Multicenter, Randomized Controlled Trial
Authors: ZePing Zhou, Yaxian Tan, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Yanliang Bai, Yunya Luo, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood (2024)
Second Primary Hematological Malignancy in Multiple Myeloma Patients Exposed to Lenalidomide and Autologous Stem Cell Transplantation
Authors: Justin Jiang, Joshua Galloway, Andrew Srisuwananukorn, Uma Borate, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Elvira Umyarova, Ashley Rosko, Abdullah Mohammad Khan, Don Benson, Francesca Cottini
Journal: Blood (2024)
Effects of Obesity on Stem Cell Transplant Outcomes in Acute Myeloid Leukemia Patients: A Systematic Review and Meta-Analysis
Authors: Sakditad Saowapa, Natchaya Polpichai, Chalothorn Wannaphut, Manasawee Tanariyakul, Diego Olavarria Bernal, Hector Garcia Pleitez, Phuuwadith Wattanachayakul, Thanathip Suenghataiphorn, Narathorn Kulthamrongsri, Maireigh McCullough, Mariana Moreira, Pharit Siladech, Tulaton Sodsri, Lukman Tijani
Journal: Blood (2024)
Upfront CPX-351 Induction at 8 Spanish Hospital. Efficacy of CPX-351 in Everyday Clinical Practice and Increased Insight into Its Use in Younger Adults
Authors: Manuel Jorge Fernández Villalobos, Javier Ortiz, Angela Figuera Alvarez, Almudena De Laiglesia, Carlos De Miguel, Virginia Pradillo Fernandez, Jordi Esteve, Marina Diaz Beya, Marta Polo, Mayte Olave, Maria del Mar Moles, Amparo Pimentel, Ramon Garcia-Sanz, Gabriela Rodriguez Macias
Journal: Blood (2024)
Real-World Experience with Elotuzumab, Pomalidomide, and Dexamethasone As Second or Third-Line Therapy in Relapsed and Refractory Multiple Myeloma
Authors: Akhil Kesaraju, Alexa Loncharich, Keith Stockerl-Goldstein, Mark A. Schroeder, Angela Vickroy, Ravi Vij, Michael Slade
Journal: Blood (2024)
Outcomes and Clinical Practice Among Patient with Chronic Lymphocytic Leukemia Treated with Ibrutinib in China: A Real-World Experience
Authors: Shenmiao Yang, Ru Feng, Xutao Guo, Zhenling Li, Qianqian Ju, Yujun Dong, Bingjie Wang, Yu Zhao, Liang Wang, Wanling Sun, Fang Fang, Liru Wang, Liping Su, Xiaojun Huang
Journal: Blood (2024)
Comparative Analysis of Patient Characteristics, Treatment Modalities, and Survival Outcomes in Chronic Lymphocytic Leukemia from China and the US
Authors: Yuting Yan, Yin Liu, Fan Yang, Jiamei Liu, Yanfei Chen, Ying Yu, Xiong Wenjie, Tingyu Wang, Zhijian Xiao, Jianxiang Wang, Thomas J. Kipps, Robert Peter Gale, Lu-Gui Qiu, Jifang Zhou, Shuhua Yi
Journal: Blood (2024)
Long Term Survivors (&amp;gt;15 years) of Multiple Myeloma: Patient Characteristics and Morbidity Burden
Authors: Rintu Sharma, Karla Alexandra Sanchez, Badraa Muharib, Esther Masih-Khan, Eshetu G. Atenafu, Harjot Vohra, Sita D. Bhella, Christine I Chen, Guido Lancman, Vishal Kukreti, Anca Prica, Donna E Reece, Rodger E Tiedemann, Suzanne Trudel, Chloe Yang, A. Keith Stewart
Journal: Blood (2024)
Comparison of Acute Kidney Injury in Patients with Relapsed or Refractory Multiple Myeloma Following CAR T-Cell and Bispecific Antibody Therapies
Authors: Noriko Nishimura, Sham Mailankody, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Tasmin Farzana, Aisha Shaikh, Sheron Latcha, Victoria Gutgarts, Eric M Jurgens, Ross S Firestone, Karthik Nath, David J. Chung, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Roni Shouval, Hamza Hashmi, Hani Hassoun, Kylee H Maclachlan, Malin Hultcrantz, Neha Korde, Alexander M. Lesokhin, Urvi A. Shah, Carlyn Rose Tan, Sergio A. Giralt, Saad Z. Usmani, Sridevi Rajeeve
Journal: Blood (2024)
Mitoxantrone Hydrochloride Liposome in Combination with Cytarabine and Venetoclax (MAV) Regimen in Relapsed or Refractory Acute Myeloid Leukemia
Authors: Huafeng Wang, Yile Zhou, Min Yang, De Zhou, Jian Huang, Liping Mao, Yinjun Lou, Wanzhuo Xie, Jie Jin
Journal: Blood (2024)
Autologous Stem Cell Transplantation for Multiple Myeloma Patients Whose Myeloma Defining Event Was Slim
Authors: Iuliana Vaxman, Shaji Kumar, Inbar Cohen, Shai O. Shimony, Angela Dispenzieri, Francis Buadi, David Dingli, Martha Lacy, Eli Muchtar, Prashant Kapoor, William J. Hogan, Suzanne R Hayman, Nelson Leung, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma M Warsame, Morie A. Gertz
Journal: Blood (2024)
Association of Glasdegib + Low-Dose Cytarabine (AraC)) in the Real-Life Treatment of Very Frail Elderly Acute Myeloid Leukemias (AML) Patients
Authors: Ilaria Tanasi, Antonella Bruzzese, Ambra Di Veroli, Calogero Vetro, Lorenzo Rizzo, Giulia De Luca, Federica Pilo, Stefano Pravato, Alfredo Molteni, Carmela Gurrieri, Prassede Salutari, Giuseppe Alberto Palumbo, Ernesto Vigna, Massimiliano Bonifacio, Marta Riva, Roberto Latagliata
Journal: Blood (2024)
FGF21 Signaling Exerts Anti-Fibrotic Properties During Pulmonary Fibrosis
Authors: Mada Ghanem, Gabrielle Archer, Aurélien Justet, Madeleine Jaillet, Eirini Vasarmidi, Pierre Mordant, Yves Castier, Hervé Mal, Aurélie Cazes, Nicolas Poté, Bruno Crestani, Arnaud Mailleux
Journal: American Journal of Respiratory and Critical Care Medicine (2024)

Idiopathic Pulmonary Fibrosis (IPF) is a lethal disease with limited therapeutic options. FGF21, an endocrine fibroblast growth factor that acts through the FGFR1/KLB pathway, mitigates liver fibrosis. We hypothesized that FGF21 could exert anti-fibrotic properties in the lung. The concentrations of FGF21 and KLB in the plasma of IPF patients and control subjects were assessed. Pulmonary fibrosis development was assessed in Fgf21-deficient mice as compared to Wild Type littermates, at Day 14 after intra-tracheal injection of bleomycin. We determined the effect of repeated subcutaneous injections of a PEGylated FGF21 analog (PEG-FGF21) at D7, 10, 14 and 17 after bleomycin on the development of pulmonary fibrosis. Mice were sacrificed at D21. The effects of FGF21, alone or with KLB, on apoptosis in MLE15 cells and on the phenotype of human lung fibroblasts were assessed in vitro. In the plasma of IPF patients, FGF21 concentration was increased, while KLB levels were decreased. Fgf21 deficient mice presented an increased sensitivity to bleomycin, in comparison to their Wild Type littermate. Treatment with PEGylated FGF21 mitigated lung fibrogenesis, as evidenced by a lower injury score, decreased fibrosis markers and pro-fibrotic mediators expression as compared to the control group receiving the diluent. In MLE15 cells, stimulation with FGF21 and KLB inhibited apoptosis, through the decrease of BAX and BIM. Fibroblastic phenotype remained unaltered. Our data indicate a possible anti-fibrotic effect of FGF21 in the lung achieved through the inhibition of alveolar type 2 cells apoptosis.
Outcomes of Patients with <i>IDH1</i>-Mutated Myeloid Neoplasms Treated with Olutasidenib
Authors: Kelly S. Chien, Koji Sasaki, Deborah McCue, Naval Daver, Tapan M. Kadia, Nicholas J. Short, Ghayas C. Issa, Guillermo Montalban-Bravo, Fadi G. Haddad, Danielle Hammond, Mahesh Swaminathan, Alexandre Bazinet, Farhad Ravandi, Guillermo Garcia-Manero, Sherry Pierce, Hagop M. Kantarjian, Courtney D. DiNardo
Journal: Blood (2024)
Real-World Results of Different Venetoclax-Containing Regimens As Induction Therapy in Acute Myeloid Leukemia: A Single-Center Retrospective Study
Authors: Minran Zhou, Zhenyi Liu, Xinwen Jiang, Shijie Li, Qingli Ji, Xiaohan Liu, Yueyue Zheng, Qing Meng, Dongmei Hu, Yuan Yu, Ran Wang, Sai Ma, Chen Chunyan
Journal: Blood (2024)
Avatrombopag Use in Patients with Persistent Thrombocytopenia Secondary to Intensive Chemotherapy Treatment
Authors: Aser Alonso Carballo, Marta Lopez Lopez-Cepero, Maria Jimenez Moya, Sandra Pérez, Lucia García Mañó, Jose Maria Sanchez Raga, Aina Oliver Caldes, Leyre Bento De Miguel, Andres Novo Garcia, Guiomar Puget Juan, Bernat Galmes Sureda, Antonio Palomero Massanet, Carlos Fernández de Larrea, Antonia Sampol Mayol, Mariana Canaro Hinryk
Journal: Blood (2024)
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia
Authors: Lin-Ya Wang, Feifei Tang, Xiao-Jun Huang, Hai-Tao Gao, Qiang Fu, Qian Jiang, Hao Jiang, Yu Wang, Lan-Ping Xu, Xiaohui Zhang
Journal: Blood (2024)
Multiple Supratherapeutic Doses of Iptacopan 400 Mg Twice Daily Are Well Tolerated in Healthy Participants: Safety Findings from a Randomized, Participant-Blinded, Placebo-Controlled, Phase I Study
Authors: Robert L Schmouder, Melissa Hackling, Bharti Shah, S. Eralp Bellibas, Kenneth Kulmatycki
Journal: Blood (2024)
Canadian Real-World Data for Acute Myeloid Leukemia Chemotherapy-Ineligible Patients on Venetoclax: An Interim Analysis from the Prospective Liven Study
Authors: Kristjan Paulson, Thomas Dunne, Lalit Saini, Nicole B. Laferriere, Michelle Geddes, Stephanie Desilets, David Sanford, Leanne Genge, Paola Lembo, Pierre-Andre Fournier, Brian Leber
Journal: Blood (2024)
Single-Dose IV Ferric Derisomaltose (1000mg given over 20 minutes) for the Treatment of Iron Deficiency Anemia in Pregnancy: A Prospective Interventional Clinical Trial (NCT05763043)
Authors: Joseph J. Shatzel, Jamie O Lo, Kylee L Martens, Thalia Padilla, Ashley E Benson, Monica Rincon
Journal: Blood (2024)
Efficacy and Safety of Gilteritinib-Based Therapy Combinated with Allo-HSCT in Relapsed or Refractory Acute Myeloid Leukemia Patients with Positive FLT3-ITD Mutation
Authors: Jian Zhang, Yang Xu, Shengli Xue, Miao Miao, Ying Wang, Suning Chen, Depei Wu, Huiying Qiu
Journal: Blood (2024)
Prognostic Impact of CD47 Overexpression in Patients with Acute Myeloid Leukemia
Authors: Vincenzo Sammartano, Elena Bestoso, Paola Pacelli, Adele Santoni, Anna Sicuranza, Marzia Defina, Corrado Zuanelli Brambilla, Mariachiara Cuccaro, Donatella Raspadori, Elisabetta Abruzzese, Monica Bocchia
Journal: Blood (2024)
Arginine Deprivation Induces a Dormient Phenotype in Neoplastic Plasma Cells: The Seed and Soil in Multiple Myeloma
Authors: Grazia Scandura, Ilaria Dulcamare, Enrico La Spina, Caterina Dieni, Daniela Cambria, Cesarina Giallongo, Daniele Tibullo, Francesco Di Raimondo, Alessandra Romano
Journal: Blood (2024)
Characterizing Treatment Patterns in Multiple Myeloma Patients with High-Risk Cytogenetics: A 15-Year-Study
Authors: Priyanka Venkatesh, Raeef L Rahman, Aroog Khaliq, Mehak M Laharwal, Shebli Atrash, Joseph P. McGuirk, Forat Lutfi, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Prerna Mewawalla, Jordan Snyder, Zahra Mahmoudjafari
Journal: Blood (2024)
Teclistamab Associated Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome: Pooled Analysis of Real-World Studies Combined with Analysis of the Faers Database
Authors: Niraj Neupane, Uttamjot Kaur, Himal Kharel, Utsav Joshi, Aakriti Parajuli, Tripti Jain, Harkarandeep Singh
Journal: Blood (2024)
DLBCL-Derived HMGB2 Inhibits Macrophage Phagocytosis By up-Regulating TRIM65 to Promote NLRP3 Ubiquitination
Authors: Sanxiu He, Yi Liu, Xiaomei Zhang, Li Jun, Huihui Fu, Yifeng Tang, Xiaoqing Xie, Qing Xiao, Liuyue Zhai, Yao Liu
Journal: Blood (2024)
Light Chain Multiple Myeloma - Clinical Characteristics and Outcomes
Authors: Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, Francis Buadi, Suzanne R Hayman, Morie A. Gertz, Angela Dispenzieri, Eli Muchtar, Prashant Kapoor, Wilson I. Gonsalves, Taxiarchis Kourelis, David Dingli, Rahma M Warsame, Nelson Leung, Joselle Cook, Moritz Binder, Yi Lin, Yi Lisa Hwa, Michelle G. Rogers, Miriam Hobbs, Amie Fonder, Dragan Jevremovic, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood (2024)
Serially Transplantable, Genetically Modified Patient Derived Xenograft Models of Acute Myeloid Leukemia Represent Primary Patients' Cells and Enable Reliable and Reproducible Preclinical Therapy Trials
Authors: Binje Vick, Vindi Jurinovic, Lena Lagally, Kristina Kuhbandner, Lisa Latzko, Chiara Arnreich, Maja Rothenberg-Thurley, Gerulf Hänel, Amelie Muth, Annika Maria Dufour, Stephanie Schneider, Maya C. Andre, Claudia D Baldus, Martin P Carroll, Martin Ebinger, Katharina S. S. Götze, Pablo Menéndez, Jean-Emmanuel Sarry, Talía Velasco-Hernández, Michael von Bergwelt-Baildon, Klaus H Metzeler, Philipp A. Greif, Marion Subklewe, Sebastian Vosberg, Tobias Herold, Karsten Spiekermann, Irmela Jeremias
Journal: Blood (2024)
Bone Disease Burden Does Not Seem to Impact Overall Survival in Newly Diagnosed Patients with Multiple Myeloma - a Detailed Imaging Analysis on 119 Patients
Authors: Evangelos Terpos, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, Stylianos Mavropoulos-Papoudas, Maria Douka, Maria Gavriatopoulou, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Lia-Angela Moulopoulos, Meletios Dimopoulos
Journal: Blood (2024)
Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity
Authors: Yang Yang, Wenjing Wang, Liang Ren, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Jing Li, Jiadai Xu, Tianhong Xu, Fei-fei Chen, Peng Liu
Journal: Blood (2024)
Phase Ⅱ Study of Chidamide in Combination with Dcag and Venetoclax for Refractory/Relapsed Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis
Authors: Qingyang Liu, Yanan Wen, Xiawei Zhang, Wenjing Gao, Daihong Liu, Liping Dou
Journal: Blood (2024)
Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity
Authors: Li Hui, FU JIyi, Boyue Zheng, Lianjie HU, Yaqiong LI, Xin WANG, Qing HU, Li Wei, Hai Yi, Ying Yuan, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Yongqian Jia
Journal: Blood (2024)
Outcomes of Double-Hit and Single High Risk Cytogenetic Newly Diagnosed Myeloma in Transplant Eligible Patients
Authors: Raeef L Rahman, Aroog Khaliq, Mehak M Laharwal, Shebli Atrash, Joseph P. McGuirk, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Prerna Mewawalla, Jordan Snyder
Journal: Blood (2024)
Outcome of Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Plus Venetoclax: A Single Center Experience in Resource Constrained Setting
Authors: Hina Peter, Parvez Ahmed, Syed Karman Mahmood, Khalil Ur Rahman, Sidra Barlas, Laila Bahadur, Qamar Un Nisa Chaudhry, Asad Ali Badshah, Summaira Naseeb, Mehroz Fatima, Ayesha Ghazanfar, Sumyyia Abbasi
Journal: Blood (2024)
A Single-Center Experience on the Safety and Efficacy of Venetoclax-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma
Authors: Eli Zolotov, Vanisha Patel, Yedidyah Weiss, Noa Biran, Pooja Phull, David H. Vesole, David S. Siegel, Harsh Parmar
Journal: Blood (2024)
Time Is Quality of Life (QoL): An Institutional Review of Emergency Department Management of Acute Vaso-Occlusive Episodes in Patients with Sickle Cell Disease
Authors: Jaime Baldeon Mendoza, Consuela Albright, Kristin Seastrand, Katrina Seedhouse, Rosa Young, Milvon Bryson, Ravi Talati, Rabi Hanna, Crawford John Strunk
Journal: Blood (2024)